Call for Proposals

DBT announces letter of intent on 'Genome Editing-based Therapeutics for Targeted Therapy of Human Diseases'

The aim of LoI is to generate proof-of-concept for the development of cost-effective genome editing-based therapeutics for diseases having a high burden in the country by focusing on various approaches in genome editing. 

Eligibility: Scientist(s)/Clinician(s)/Researcher(s)/Academician(s) with sound and relevant scientific/clinical and technical backgrounds and relevant publications working in regular capacity in recognized Research Institutions/Medical Colleges/Academic Institutions desirous of undertaking research activities as enumerated above can submit LoIs against this Call. For non-government institutions, DSIR-recognition as a Scientific and Industrial Research Organization (SIRO) is a must. The host institution should undertake the overall responsibility of implementing the project including following of relevant statutory requirements/norms/guidelines/procedures.

 Last date: Saturday, December 31, 2022